These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31040250)

  • 1. Low gonorrhoea antimicrobial resistance and culture positivity rates in general practice: a pilot study.
    Visser M; van Westreenen M; van Bergen J; van Benthem BHB
    Sex Transm Infect; 2020 May; 96(3):220-222. PubMed ID: 31040250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and determinants of antimicrobial susceptibility of
    Hofstraat SH; Götz HM; van Dam AP; van der Sande MA; van Benthem BH
    Euro Surveill; 2018 Sep; 23(36):. PubMed ID: 30205870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany.
    Horn NN; Kresken M; Körber-Irrgang B; Göttig S; Wichelhaus C; Wichelhaus TA;
    Int J Med Microbiol; 2014 Jul; 304(5-6):586-91. PubMed ID: 24801146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014-2017.
    Yéo A; Kouamé-Blavo B; Kouamé CE; Ouattara A; Yao AC; Gbedé BD; Bazan F; Faye-Ketté H; Dosso M; Wi T; Unemo M
    Sex Transm Dis; 2019 Mar; 46(3):179-184. PubMed ID: 30461598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys.
    Clifton S; Bolt H; Mohammed H; Town K; Furegato M; Cole M; Campbell O; Fifer H; Hughes G
    J Antimicrob Chemother; 2018 Apr; 73(4):923-932. PubMed ID: 29394396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in
    Hernando Rovirola C; Spiteri G; Sabidó M; Montoliu A; Gonzalez V; Casabona J; Cole MJ; Noori T; Unemo M
    Sex Transm Infect; 2020 May; 96(3):204-210. PubMed ID: 32019895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
    Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM
    Emerg Infect Dis; 2017 Sep; 23(9):1478-1485. PubMed ID: 28820128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme.
    Hançali A; Ndowa F; Bellaji B; Bennani A; Kettani A; Charof R; El Aouad R
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv24-7. PubMed ID: 24037141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013.
    Lebedzeu F; Golparian D; Titov L; Pankratava N; Glazkova S; Shimanskaya I; Charniakova N; Lukyanau A; Domeika M; Unemo M
    BMC Infect Dis; 2015 Jan; 15():29. PubMed ID: 25637258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.
    Kirkcaldy RD; Kidd S; Weinstock HS; Papp JR; Bolan GA
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv5-10. PubMed ID: 24243881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.